Serum PCSK9 was nevertheless positively correlated with steatosis grade, necroinflammation, hepatocyte ballooning, and fibrosis stage in the second cohort of patients with NAFLD. This evidence concerns the gene PCSK9 and metabolic dysfunction-associated steatotic liver disease.